Page last updated: 2024-11-07

methylprednisolone acetate and Anemia, Sickle Cell

methylprednisolone acetate has been researched along with Anemia, Sickle Cell in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J1
Perese, F1
Rubin, LE1
Carlyle, D1

Other Studies

1 other study available for methylprednisolone acetate and Anemia, Sickle Cell

ArticleYear
Effective Pain Management After Total Hip Arthroplasty in a Sickle Cell Patient Emphasizing Dexamethasone Sodium Phosphate/Methylprednisolone Acetate Administered via a Peripheral Nerve Blockade: A Case Report.
    A&A practice, 2019, Mar-01, Volume: 12, Issue:5

    Topics: Adult; Anemia, Sickle Cell; Anti-Inflammatory Agents; Arthroplasty, Replacement, Hip; Autonomic Nerv

2019